Drug Shortage Report for APO-HYDROMORPHONE CR
Report ID | 77849 |
Drug Identification Number | 02476657 |
Brand name | APO-HYDROMORPHONE CR |
Common or Proper name | HYDROMORPHONE |
Company Name | APOTEX INC |
Market Status | DORMANT |
Active Ingredient(s) | HYDROMORPHONE HYDROCHLORIDE |
Strength(s) | 12MG |
Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
Route of administration | ORAL |
Packaging size | 60 BTL |
ATC code | N02AA |
ATC description | OPIOIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-04-19 |
Actual start date | |
Estimated end date | |
Actual end date | 2019-12-30 |
Shortage status | Resolved |
Updated date | 2020-04-04 |
Company comments | Product is discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2020-04-04 | French | Compare |
v6 | 2020-04-04 | English | Compare |
v5 | 2019-04-20 | English | Compare |
v4 | 2019-03-07 | French | Compare |
v3 | 2019-03-07 | English | Compare |
v2 | 2019-03-05 | French | Compare |
v1 | 2019-03-05 | English | Compare |
Showing 1 to 7 of 7